HELEN CHODSKY: Open Payments
NPI 1376868497 · BERKELEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,099 in 70 payments from 16 companies in 2025. Trend: 2023 $1,378 · 2024 $2,262 · 2025 $2,099
Food & beverage: $2,032Education: $67
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $652 |
| Galderma Laboratories, L.P. | 7 | $287 |
| LEO Pharma Inc. | 14 | $263 |
| ABBVIE INC. | 10 | $196 |
| Incyte Corporation | 5 | $194 |
| Lilly USA, LLC | 4 | $193 |
| GENZYME CORPORATION | 3 | $65 |
| Journey Medical Corporation | 1 | $36 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| PFIZER INC. | 1 | $28 |
Products named: TREMFYA, NEMLUVIO, ADBRY, OPZELURA, SKYRIZI, EBGLYSS, DUPIXENT, TALTZ.
Industry payments across CA — which companies pay providers there.
